Extraordinary Measures

Last updated

Extraordinary Measures
Extraordinary measures poster.jpg
Theatrical release poster
Directed by Tom Vaughan
Written by Robert Nelson Jacobs
Based onThe Cure: How a Father Raised $100 Million — And Bucked the Medical Establishment — in a Quest to Save His Children
by Geeta Anand
Produced by
Starring
Cinematography Andrew Dunn
Edited by Anne V. Coates
Music by Andrea Guerra
Production
company
Double Feature Films
Distributed by CBS Films (North America)
Sony Pictures Releasing International (International) [1] [2]
Release date
  • January 22, 2010 (2010-01-22)
Running time
106 minutes
CountryUnited States
LanguageEnglish
Budget$31 million [3]
Box office$15 million [3]

Extraordinary Measures is a 2010 American medical drama film starring Brendan Fraser, Harrison Ford, and Keri Russell. It was the first film produced by CBS Films, the film division of CBS Corporation, who released the film on January 22, 2010. The film is about parents who form a biotechnology company to develop a drug to save the lives of their children, who have a life-threatening disease. The film is based on the true story of John and Aileen Crowley, whose children have Pompe's disease. The film was shot in St. Paul, Oregon; Portland, Oregon; Tualatin, Oregon; Wilsonville, Oregon; Manzanita, Oregon; Beaverton, Oregon, and Vancouver, Washington.

Contents

Plot

John Crowley and his wife Aileen are a Portland couple with two of their three children suffering from Pompe disease, a genetic anomaly that typically kills most children before their tenth birthdays. John, an advertising executive, contacts Robert Stonehill, a researcher in Nebraska who has done innovative research for an enzyme treatment for the rare disease. John and Aileen raise money to help Stonehill's research and the required clinical trials.

John takes on the task full-time to save his children's lives, launching a biotechnology research company working with venture capitalists and then rival teams of researchers. This task proves very daunting for Stonehill, who already works around the clock. As time is running short, Stonehill's angry outburst hinders the company's faith in him, and the profit motive may upend John's hopes. The researchers race against time to save the children who have the disease.

Cast

John Crowley makes a cameo appearance as a venture capitalist.

Production

Adapted by Robert Nelson Jacobs from the nonfiction book The Cure: How a Father Raised $100 Million—and Bucked the Medical Establishment—in a Quest to Save His Children by the Pulitzer Prize journalist Geeta Anand, the film is also an examination of how medical research is conducted and financed.

Filming in May 2009 at Pioneer Courthouse Square in Portland, Oregon Filming of Extraordinary Measures in Portland, Oregon.JPG
Filming in May 2009 at Pioneer Courthouse Square in Portland, Oregon

Filming took place at several spots in and around Portland, Oregon, mostly at the OHSU Doernbecher Children's Hospital, Veterans Affairs Medical Center and the Nike campus in Beaverton, Oregon. This was the first time Nike allowed filming on their campus and they donated the location payment to Doernbecher Children’s Hospital. [4] During filming, the working title was The Untitled Crowley Project. [5]

In the film, the children are 9 and 7 years old. Their non-fiction counterparts were diagnosed at 15 months and 7 days old and received treatment at 5 and 4, respectively. [6]

Inspiration

Myozyme, a drug developed for treating Pompe disease, was simultaneously approved for sale by the US Food and Drug Administration and the European Medicines Agency. Henceforth, more than 1000 infants born worldwide every year with Pompe disease will no longer face the prospect of death before reaching their first birthday for lack of a treatment for the condition.

The screenplay by Robert Nelson Jacobs is based on Geeta Anand's book The Cure ( ISBN   9780060734398). [7] Parts of the book first appeared as a series of articles in The Wall Street Journal .

The small start-up company Priozyme was based on Oklahoma City-based Novazyme. The larger company, called Zymagen in the film, was based on Genzyme in Cambridge, Massachusetts. [8] Novazyme was developing a protein therapeutic, with several biological patents pending, to treat Pompe Disease, when it was bought by Genzyme. The patent portfolio was cited in the press releases announcing the deal. [9]

Genzyme claims that Dr. Robert Stonehill's character is based upon scientist and researcher William Canfield, [10] who founded Novazyme. [11] According to Roger Ebert's review, the character is based on Yuan-Tsong Chen, [6] a scientist and researcher from Duke University [12] who collaborated with Genzyme in producing Myozyme, the drug which received FDA approval.

Reception

Critical response

Review aggregation website Rotten Tomatoes gives the film an approval rating of 29% based on reviews from 142 critics and an average rating of 4.88 out of 10. The site's general consensus is, "Despite a timely topic and a pair of heavyweight leads, Extraordinary Measures never feels like much more than a made-for-TV tearjerker." [13] Metacritic, which assigns a weighted average score out of 0–100 reviews from film critics, has a rating score of 45 based on 33 reviews. [14] Audiences polled by CinemaScore gave the film an average grade of "A-" on an A+ to F scale. [15]

Richard Corliss of Time magazine wrote: "Fraser keeps the story anchored in reality. Meredith Droeger does too: as the Crowleys' afflicted daughter, she's a smart little bundle of fighting spirit. So is the movie, which keeps its head while digging into your heart. You have this critic's permission to cry in public." [16] The New York Times' A. O. Scott said in his review: "The startling thing about Extraordinary Measures is not that it moves you. It's that you feel, at the end, that you have learned something about the way the world works." [17]

Ramona Bates MD, writing for the health news organisation, EmaxHealth, stated that the film brings attention to Pompe disease. [18] Peter Rainer from The Christian Science Monitor mentions that Big Pharma got a surprisingly free pass in the film and that it will come as a surprise to all those sufferers struggling to get orphan drugs developed. [19]

Jef Akst, writing for the journal The Scientist, stated that the film is good depiction of the "hard to swallow fiscal issues of drug development." [20]

Box office

The film opened at #8 on its opening weekend, taking in $6 million. The film remained in theaters for four weeks, earning $12 million.

Related Research Articles

<span class="mw-page-title-main">Keri Russell</span> American actress (born 1976)

Keri Lynn Russell is an American actress. She portrayed the titular character on the drama series Felicity (1998–2002), which won her a Golden Globe Award, and Elizabeth Jennings on the FX spy thriller series The Americans (2013–2018), which earned her nominations for several Primetime Emmy and Golden Globe Awards.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.

<span class="mw-page-title-main">Alan Ruck</span> American actor (born 1956)

Alan Douglas Ruck is an American actor. He is best known for portraying Cameron Frye, Ferris Bueller's best friend, in John Hughes's film Ferris Bueller's Day Off (1986); Stuart Bondek, a lecherous, power-hungry member of the mayor's staff in the ABC sitcom Spin City; and Connor Roy, the eldest son of a media magnate, in the HBO series Succession. His other notable parts include those in Bad Boys (1983), Three Fugitives (1989), Young Guns II (1990), Speed (1994), and Twister (1996). In 2016, he co-starred with Geena Davis in an updated Fox TV adaptation of William Peter Blatty's best-selling novel The Exorcist.

<span class="mw-page-title-main">Glycogen storage disease type II</span> Medical condition

Glycogen storage disease type II, also called Pompe disease, is an autosomal recessive metabolic disorder which damages muscle and nerve cells throughout the body. It is caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme. It is the only glycogen storage disease with a defect in lysosomal metabolism, and the first glycogen storage disease to be identified, in 1932 by the Dutch pathologist J. C. Pompe.

<span class="mw-page-title-main">Joel David Moore</span> American character actor and director

Joel David Moore is an American character actor and director. Born and raised in Portland, Oregon, Moore studied acting in college before relocating to Los Angeles to pursue a film career. His first major role was as Owen Dittman in the 2004 comedy Dodgeball: A True Underdog Story, followed by roles in the comedy Grandma's Boy (2006), Terry Zwigoff's Art School Confidential (2006), and the independent slasher film Hatchet (2006).

Oregon Health & Science University (OHSU) is a public research university focusing primarily on health sciences with a main campus, including two hospitals, in Portland, Oregon. The institution was founded in 1887 as the University of Oregon Medical Department and later became the University of Oregon Medical School. In 1974, the campus became an independent, self-governed institution called the University of Oregon Health Sciences Center, combining state dentistry, medicine, nursing, and public health programs into a single center. It was renamed Oregon Health Sciences University in 1981 and took its current name in 2001, as part of a merger with the Oregon Graduate Institute (OGI), in Hillsboro. The university has several partnership programs including a joint PharmD Pharmacy program with Oregon State University in Corvallis.

<span class="mw-page-title-main">Shriners Hospital for Children (Portland)</span> Hospital in Oregon, United States

The Shriners Children's Portland is a 29-bed, non-profit pediatric hospital located in Portland, in the U.S. state of Oregon. It specializes in orthopedics, cleft lip, and palate disorders as part of the 22-hospital system belonging to the Shriners Hospitals for Children. Established in 1924, the current campus opened in 1983. The hospital is located on the Oregon Health and Science University campus, and is active in the research and development of new technology.

The Duke University School of Medicine, commonly known as Duke Med, is the medical school of Duke University. It is located in the Collegiate Gothic-style West Campus of Duke University in Durham, North Carolina. The School of Medicine, along with the Duke University School of Nursing, Duke University Hospital, Duke Regional Hospital, Duke Children's Hospital, Duke Raleigh Hospital, and other affiliated hospitals, clinics, and laboratories, make up the Duke University Health System. Established in 1925 by James B. Duke, the School of Medicine has earned its reputation as an integral part of one of the world's foremost patient care and biomedical research institutions.

<i>Mans Best Friend</i> (1993 film) 1993 film by John Lafia

Man's Best Friend is a 1993 American science fiction horror film, directed and written by John Lafia. It stars Ally Sheedy, Lance Henriksen, Robert Costanzo, Frederic Lehne, John Cassini, and J. D. Daniels.

Sheridan Gray Snyder OBE is an entrepreneur, venture capitalist, and philanthropist in the biotechnology industry. He is the founder and CEO of Biocatalyst, but also a "serial entrepreneur", a founder of Genzyme and many other companies. Snyder, who was the University of Virginia's best tennis player when he was studying for his BA in French and Romance Languages there in the 1960s, made "major contributions to the popularisation of tennis in the USA." He co-founded the National Junior Tennis League that reaches 250,000 inner-city young people and constructed a new tennis center at the University of Virginia.

Iduronidase, sold as Aldurazyme, is an enzyme with the systematic name glycosaminoglycan alpha-L-iduronohydrolase. This enzyme catalyses the hydrolysis of unsulfated alpha-L-iduronosidic linkages in dermatan sulfate.

Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease, a rare lysosomal storage disorder (LSD). Chemically, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease.

<span class="mw-page-title-main">John Crowley (biotech executive)</span> American biotechnology executive and entrepreneur

John Francis Crowley is an American biotechnology executive and entrepreneur and the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme Corporation, and founded Orexigen Therapeutics. In 2006, he was profiled in the book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children by Geeta Anand. In 2010, Crowley released his memoir, Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. Crowley and his family were the inspiration for the movie Extraordinary Measures starring Harrison Ford and Brendan Fraser in 2010.

<span class="mw-page-title-main">Brian Druker</span>

Brian J. Druker is a physician-scientist at Oregon Health & Science University, in Portland, Oregon. He is the director of OHSU's Knight Cancer Institute, Jeld-Wen Chair of Leukemia Research, and professor of medicine. In 2009, he won the Lasker-DeBakey Clinical Medical Research Award and the Meyenburg Award for his influential work in the development of imatinib for the treatment of chronic myeloid leukemia (CML). He has been called "Oregon's best-known scientist".

William Canfield is a glycobiologist, chief scientific officer and founder of an Oklahoma City-based biotechnology company, Novazyme, which was acquired by Genzyme in August 2001 and developed, among other things, an enzyme that can stabilize Pompe disease, based on Canfield's ongoing research since 1998. Canfield subsequently left Genzyme and established, with his partner in the Novazyme operation, John Crowley, another research laboratory, which he still heads. He saved Cytovance from bankruptcy by forming an investor group and raising $9 million after Crowley suddenly left the lab in 2005 to become the chief executive officer at Amicus Therapeutics in New Jersey

<span class="mw-page-title-main">Henri Termeer</span>

Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.

<span class="mw-page-title-main">Ionis Pharmaceuticals</span> Biotechnology company

Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza (Nusinersen), Tegsedi (Inotersen), and Waylivra (Volanesorsen) and has 4 drugs in pivotal studies: tominersen for Huntington’s disease, tofersen for SOD1-ALS, AKCEA-APO(a)-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.

<span class="mw-page-title-main">Markus Grompe</span>

Markus Grompe is a professor of Pediatrics and practicing physician at Oregon Health & Science University. since 1991. Since 2004, he has been director of the Oregon Stem Cell Center at OHSU. Until 2018, he was also director of the Papé Family Pediatric Research Institute, Vice Chair for research in the OHSU department of Pediatrics, and holder of the Ray Hickey Endowed Chair at Doernbecher Children's Hospital.

Yuan-Tsong Chen is a Taiwanese physician scientist, notable for his work on human genetic disorders. He is the director emeritus (2001–2010) and distinguished research fellow (2001–present) of the Institute of Biomedical Sciences, Academia Sinica, Taiwan, and also tenured professor of pediatrics of Duke University (1993–present) Chen was a 2019 awardee of Taiwan's Presidential Science Award, as were Yuan-Pern Lee and Wei Fu-chan.

Avalglucosidase alfa, sold under the brand name Nexviazyme, is an enzyme replacement therapy medication used for the treatment of glycogen storage disease type II.

References

  1. ↑ Goodridge, Mike (January 21, 2010). "Extraordinary Measures". Screen International . Retrieved September 19, 2021.
  2. ↑ "CBS Films hooks up with Sony". Variety . November 17, 2009. Retrieved September 19, 2021.
  3. 1 2 "Extraordinary Measures (2010)". Box Office Mojo . Internet Movie Database . Retrieved January 25, 2010.
  4. ↑ "'Extraordinary Measures,' filmed in Portland and starring Brendan Fraser and Harrison Ford, opens Friday". The Oregonian . Advance Publications. January 21, 2010. Archived from the original on September 23, 2012. Retrieved January 25, 2010.
  5. ↑ "On the 'Crowley' set: Boredom, action and a bit of politics". The Oregonian . Advance Publications. June 2, 2009. Archived from the original on October 6, 2012. Retrieved January 25, 2010.
  6. 1 2 Roger Ebert (January 20, 2010). Extraordinary Measures. Sun Times. Accessed 2011-08-01.
  7. ↑ A. O. Scott (January 22, 2010). "Desperate Father's Plea to a Detached Scientist". NY Times.
  8. ↑ Jef Akst (January 22, 2010). "A review of Extraordinary Measures". The Scientist NewsBlog.
  9. ↑ "Proprietary Glycoprotein Technology Platform Will Advance Lysosomal Storage Disorder Programs". prnewswire.com. Archived from the original on May 9, 2012. Retrieved January 16, 2023.
  10. ↑ "FAQs". genzyme.com. Archived from the original on January 25, 2010.
  11. ↑ ""Extraordinary Measures" Father Coming to Norfolk " The Health Journal: Fitness, Nutrition, Wellness". Thehealthjournals.com. Archived from the original on March 28, 2012. Retrieved April 12, 2013.
  12. ↑ "Research Divisions". Ibms.sinica.edu.tw. Archived from the original on January 9, 2014. Retrieved April 12, 2013.
  13. ↑ "Extraordinary Measures (2010)". Rotten Tomatoes . Flixster . Retrieved May 10, 2020.
  14. ↑ "Extraordinary Measures: Reviews". Metacritic . CNET Networks . Retrieved January 25, 2010.
  15. ↑ "Home". CinemaScore . Retrieved February 28, 2022.
  16. ↑ Corliss, Richard (February 1, 2010). "Extraordinary Measures: Sentiment Makes a Comeback". Time. Archived from the original on January 25, 2010.
  17. ↑ Scott, A. O. (January 22, 2010). "Desperate Father's Plea to a Detached Scientist". The New York Times.
  18. ↑ EmaxHealth. ""Extraordinary Measures" Brings Attention Pompe Disease".
  19. ↑ Peter Rainer (January 22, 2010). "Extraordinary Measures Movie Review".
  20. ↑ "A review of Extraordinary Measures".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.